PREMSTEM is a collective of world leading clinicians, researchers, stakeholder advocacy groups and an industrial partner with well-established experience in neonatology and drug development. We are developing a new regenerative stem cell therapy to repair the brain damage caused by premature birth, also known as encephalopathy of prematurity (EOP). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874721. Posts and results reflect the author’s view only. The European Commission is not responsible for any use that may be made of the information it contains.